Berwyn-Based Pharmaceutical Company Takes Over-the-Counter Route for Approval of Its New Drug Candidate | Virpax Pharmaceuticals

Jul 28, 2022

Berwyn-Based Pharmaceutical Company Takes Over-the-Counter Route for Approval of Its New Drug Candidate

admin2022-10-21T08:31:56-04:00July 28th, 2022|Media|

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

Nasdaq_Logo_wht

NASDAQ: VRPX

Corporate Headquarters
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312

Phone 610.727.4597
Email info@virpaxpharma.com

© Virpax^® Pharmaceuticals. All Rights Reserved.

© Virpax^® Pharmaceuticals. All Rights Reserved.

Follow @VirpaxPharma

Follow @VirpaxPharma